JAPAN TIMES に載った模倣に関する記事です。JAPAN TIMESの許可の下、掲載させていただきます。一部の写真につき、著作権上の問題で、掲載を省略してありますので、ごらんになりたい方は、JAPAN TIMES ホームページでごらん下さい。
遠山 勉(03/01/24)
Faking it
Now there's
an unoriginal idea
By SETSUKO KAMIYA
Staff writer
Fakes and copies -- the words conjure up images of brand-name goods that
aren't; trademarks purloined; forged money and passports; pirated CDs, software
and videos . . . and even archaeological finds that weren't as historic as they
were purported to be.
|
The |
But look again. In the same society where
such surrogates are frowned upon -- or even considered criminal -- there are
many doubles that simply don't fit the negative stereotype.
More than that, fakes (things that pretend to
be what they are not) and copies (reproductions of an "authentic"
original) can be beneficial, educational or simply more accessible than the
real thing. Whether it's patented drugs that put breakthrough treatments within
the reach of developing countries, or an Impressionist print in a classroom
that helps kids to appreciate art, many fakes and copies have a crucial role to
play.
Take the copies that are, in some cases, the
only evidence left that an original ever existed. Some of Japan's most famous
landmarks are replicas: Osaka Castle (destroyed in 1868, rebuilt in 1931 and
refurbished after World War II -- complete with elevator); or Kyoto's Kinkakuji
Temple (rebuilt in 1955 after being burned to the ground in 1950).
These copies aren't mere reproductions --
they fire the imagination with their evocation of times past. In the museum
collection of the
The French
At Walt Disney World in the
Of course, a Plasticine dummy can't tell you
that much, but copies can be invaluable learning aids, giving access to places
and objects otherwise beyond our reach. In many ways, copying is the heart of
an educational experience.
"Kids learn from their parents by
copying," says Tokyo-based patent attorney Tsutomu Toyama. "Without
the freedom to copy, I don't think society, culture or the individual can
grow."
The arts have always made use of copying as a
discipline for those learning their craft, whether they are painters, potters,
writers or actors. As Yoshiaki Nishino, professor of museum technology at the
Nishino was the driving force behind an
exhibition at the
It's the same with the performing arts --
theater, music and dance. According to entertainment critic Noboru Saijyo,
"Entertainers begin by copying their masters, and they gradually begin to
develop their own styles."
Individuals aren't the only ones learning by
copying. During the Meiji Era,
One homegrown entrepreneurial innovation,
however, was a breakthrough made by Kokichi Mikimoto at the turn of the 20th
century. He was the first to successfully culture pearls by farming pearl
oysters. Thanks to Mikimoto's discovery,
But though no one, surely, would choose fake
pearls over a string of Mikimoto's iridescent cultured pearls, the price-tag
may mean that many have to settle for fakes after all. This is the familiar
face of the "fake": the handbag that almost -- but not quite --
resembles that of a designer brand; the shirt with a familiar logo at a
rock-bottom price. These things are cheaper, sure, but second-best -- aren't
they?
It's not always like that. If you want to
look good without emptying your wallet, it can make sense to opt for a fake.
Brand-name rip-offs may be illegal, but fake leather and fur do a convincing
imitations of the real thing at a fraction of the cost. What's more, they don't
cost any creature its skin -- a powerful incentive for many buyers.
Speaking of which, animals have long used
sophisticated forms of "fakery" as a way of saving their skins. Imitation
is the evolutionary key to the survival of numerous species. Probably the
best-known example is the cuckoo. The eggs of this wily avian are almost
identical to those of the birds -- often shrikes or buntings -- in whose nests
it lays them. In this way, the hatchling is reared by the unwitting foster
parents, freeing the adult cuckoo of all parental responsibilities.
In the insect world, mimicry takes some
fascinating forms. Wasps, for example, aren't striped black-and-yellow by
accident. They're examples of what is known as Millerian mimicry: Their colored
stripes have evolved as a defense, a warning signal to would-be predators that
they pack a powerful sting.
Also cashing in on this evolutionary benefit
are "fakes" such as the hover fly, which, through a process known as
Batesian mimicry, has come to resemble a wasp. Its stripes keep predators at
bay, even though it has no sting.
In both nature and society, fakes and copies
can have a valuable role. They even entertain us -- who hasn't laughed at the
skill of a comedian's successful impersonation? This showbiz take on imitation
has cultural roots stretching back centuries. Japanese audiences enjoyed shows
of mimicry as early as the 14th century, says critic Saijyo. Early kyogen
comedians imitated animals, and in the later years of the Edo Period, kabuki
actors were the role models of popular professional mimics called kowairoya who
performed in amusement districts.
That tradition continues to this day, Saijyo
points out, with most TV stations hosting high-rating shows featuring mimics
and impersonators. Popular comedians like Tamori and Akashiya Sanma started out
by mimicking celebrities -- and are now impersonated in turn by other
entertainers.
There's less to laugh about, perhaps, when we
turn to the future of fakery and copying. "Most new technologies are
developed based on earlier discoveries, which means copying is virtually
unavoidable," says patent attorney
That calls for careful regulation of
intellectual property issues,
Patents are at the heart of the current
controversy over generic drugs -- chemically identical "copies" of
medicines developed and patented by major pharmaceutical companies. Generic
drugs retail at an average $17 per prescription, according to a statement by
President George W. Bush on Oct. 21., compared to $72 for the brand-name
equivalent. Since the development of a single drug can cost up to $800 million,
patents are critical in safeguarding a company's investment.
However, some question the refusal of
companies such as Glaxo-Wellcome, developer of HIV-drug AZT, to allow generic
copying of drugs still under patent. The brand-name pharmaceuticals are too
costly for countries such as
And if one subject promises to dominate
future scientific discourse, it is also to do with our ability (and right) to
produce copies -- of humans. Cloning of human beings may be close to becoming
reality, and lawyers, psychologists and philosophers are already asking what
manner of person such a human "copy" would be, with what rights and
what identity. As it should be clear by now, not all copies are inherently
"bad" -- but not even the experts know what human cloning will bring.
The
(C) All
rights reserved